Thema
Adalimumab
18
FYS6T7F842
18
Journal Article
18
Research Support, Non-U.S. Gov't
B72HH48FLU
17
Infliximab
17
Anti-Inflammatory Agents
8
Crohn’s disease
8
Gastrointestinal Agents
8
Inflammatory bowel disease
8
Tumor Necrosis Factor-alpha
8
Antibodies, Monoclonal, Humanized
6
Biological Products
5
Anti-TNF
4
Antibodies, Monoclonal
3
Research Support, N.I.H., Extramural
3
Tumor Necrosis Factor Inhibitors
3
Ulcerative colitis
3
9RV78Q2002
2
Anti-tumor necrosis factor
2
Comparative Study
2
FU77B4U5Z0
2
Immunologic Factors
2
Loss of response
2
Multicenter Study
2
Ustekinumab
2
vedolizumab
2
3WJQ0SDW1A
1
87LA6FU830
1
9007-41-4
1
97C5T2UQ7J
1
Adrenal Cortex Hormones
1
Anti-TNF agents
1
Anti-TNFα
1
Anti-integrin
1
Antibodies
1
Antibodies, Bacterial
1
Antineoplastic Agents
1
Biologic therapy
1
Biological Factors
1
Biological therapy
1
C-Reactive Protein
1
Case Reports
1
Certolizumab Pegol
1
Cholesterol
1
Cholesterol, LDL
1
Comparative effectiveness
1
Comparative safety
1
Efficacy
1
Epidemiology
1
mehr ...